Search

Your search keyword '"Avolio, C."' showing total 211 results

Search Constraints

Start Over You searched for: Author "Avolio, C." Remove constraint Author: "Avolio, C."
211 results on '"Avolio, C."'

Search Results

1. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

2. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

3. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

4. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

5. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis

6. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

7. Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS register

8. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

9. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

10. List of Contributors

13. The Italian multiple sclerosis register

14. Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment

16. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

17. Fluctuations of MS births and UV-light exposure

18. Effectiveness of Natalizumab on Multiple Sclerosis patients: the Italian registry experience

19. No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

20. No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

21. Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: A multicenter study

22. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

24. First-aid management of tonic-clonic seizures among healthcare personnel: A survey by the Apulian section of the Italian League Against Epilepsy

25. Prognostic Indicators in Pediatric Clinically Isolated Syndrome

26. Predictors of definite Multiple Sclerosis in patients with pediatric onset first demyelinating clinical attack

27. La dirigenza della Regione Campania e i 'fondi strutturali europei''

28. Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment

29. Real-life impact of early interferon beta therapy in relapsing multiple sclerosis

30. post marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in intereron beta treatment

31. rel-life impact of early interferon beta therapy in relapsing multiple sclerosis

32. Heterogeneous impact of an early IFN beta treatment on disability progression in relapsing remitting MS subgroups with differnt baseline clinical profiles

34. Gender ratio of multiple sclerosis in Italy: geographical distribution and trend over 60 years

35. Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

38. Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination

43. Fluctuations of MS births and UV-light exposure

46. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment

Catalog

Books, media, physical & digital resources